XWELL Price to Free Cash Flow Ratio 2011-2025 | XWEL
Historical price to free cash flow ratio values for XWELL (XWEL) since 2011.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| XWELL Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-11-11 | 0.85 | 0.00 | |
| 2025-06-30 | 0.92 | $-3.09 | 0.00 |
| 2025-03-31 | 1.02 | $-2.70 | 0.00 |
| 2024-12-31 | 1.51 | $-2.77 | 0.00 |
| 2024-09-30 | 1.73 | $-2.61 | 0.00 |
| 2024-06-30 | 1.80 | $-3.08 | 0.00 |
| 2024-03-31 | 1.69 | $-3.51 | 0.00 |
| 2023-12-31 | 1.74 | $-4.31 | 0.00 |
| 2023-09-30 | 2.25 | $-5.12 | 0.00 |
| 2023-06-30 | 4.00 | $-6.25 | 0.00 |
| 2023-03-31 | 7.20 | $-7.61 | 0.00 |
| 2022-12-31 | 7.20 | $-6.55 | 0.00 |
| 2022-09-30 | 15.40 | $-3.57 | 0.00 |
| 2022-06-30 | 13.80 | $0.05 | 299.35 |
| 2022-03-31 | 22.60 | $2.17 | 10.42 |
| 2021-12-31 | 40.40 | $1.96 | 20.65 |
| 2021-09-30 | 29.40 | $-5.83 | 0.00 |
| 2021-06-30 | 30.80 | $-7.03 | 0.00 |
| 2021-03-31 | 36.80 | $-0.82 | 0.00 |
| 2020-12-31 | 23.80 | $-13.01 | 0.00 |
| 2020-09-30 | 39.40 | $-18.93 | 0.00 |
| 2020-06-30 | 83.80 | $-18.96 | 0.00 |
| 2020-03-31 | 11.40 | $-29.63 | 0.00 |
| 2019-12-31 | 40.20 | $-29.23 | 0.00 |
| 2019-09-30 | 86.40 | $-103.57 | 0.00 |
| 2019-06-30 | 116.40 | $-160.06 | 0.00 |
| 2019-03-31 | 144.00 | $-244.09 | 0.00 |
| 2018-12-31 | 192.00 | $-396.06 | 0.00 |
| 2018-09-30 | 180.00 | $-563.59 | 0.00 |
| 2018-06-30 | 348.00 | $-586.79 | 0.00 |
| 2018-03-31 | 864.00 | $-698.46 | 0.00 |
| 2017-12-31 | 1644.00 | $-896.91 | 0.00 |
| 2017-09-30 | 1668.00 | $-1,066.68 | 0.00 |
| 2017-06-30 | 1980.00 | $-1,280.03 | 0.00 |
| 2017-03-31 | 2604.00 | $-576.07 | 0.00 |
| 2016-12-31 | 2556.00 | $-673.13 | 0.00 |
| 2016-09-30 | 3228.00 | $1,036.23 | 3.12 |
| 2016-06-30 | 2268.00 | $719.37 | 3.15 |
| 2016-03-31 | 1968.00 | $-312.15 | 0.00 |
| 2015-12-31 | 2964.00 | $-301.97 | 0.00 |
| 2015-09-30 | 6720.00 | $-2,733.58 | 0.00 |
| 2015-06-30 | 6720.00 | $-2,998.21 | 0.00 |
| 2015-03-31 | 7800.00 | $-3,043.94 | 0.00 |
| 2014-12-31 | 6600.00 | $-3,796.78 | 0.00 |
| 2014-09-30 | 11400.00 | $-3,608.44 | 0.00 |
| 2014-06-30 | 41040.00 | $-3,565.76 | 0.00 |
| 2014-03-31 | 41640.00 | $-3,873.79 | 0.00 |
| 2013-12-31 | 35520.00 | $-3,384.74 | 0.00 |
| 2013-09-30 | 34440.00 | $-5,394.13 | 0.00 |
| 2013-06-30 | 38040.00 | $-5,822.20 | 0.00 |
| 2013-03-31 | 38040.00 | $-4,940.76 | 0.00 |
| 2012-12-31 | 34440.00 | $-4,227.28 | 0.00 |
| 2012-09-30 | 34800.00 | $-1,260.09 | 0.00 |
| 2012-06-30 | 46320.00 | $0.14 | 325280.90 |
| 2012-03-31 | 19800.00 | $-0.20 | 0.00 |
| 2011-12-31 | 11880.00 | $-0.18 | 0.00 |
| 2011-09-30 | 17040.00 | $-1.23 | 0.00 |
| 2011-06-30 | 14640.00 | $-2.55 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $152.423B | 27.99 |
| HCA Healthcare (HCA) | United States | $105.496B | 17.47 |
| CVS Health (CVS) | United States | $101.390B | 11.66 |
| Cencora (COR) | United States | $70.781B | 22.83 |
| Elevance Health (ELV) | United States | $70.061B | 10.27 |
| Natera (NTRA) | United States | $28.530B | 0.00 |
| DiDi Global (DIDIY) | China | $25.745B | 21.04 |
| Labcorp Holdings (LH) | United States | $22.235B | 16.95 |
| Medpace Holdings (MEDP) | United States | $16.979B | 42.15 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.630B | 0.00 |
| ICON (ICLR) | Ireland | $13.197B | 13.10 |
| Viatris (VTRS) | United States | $12.900B | 4.81 |
| Solventum (SOLV) | United States | $12.814B | 12.44 |
| CochLear (CHEOY) | Australia | $12.308B | 0.00 |
| Revvity (RVTY) | United States | $10.692B | 19.69 |
| HealthEquity (HQY) | United States | $8.601B | 34.42 |
| Charles River Laboratories (CRL) | United States | $8.539B | 16.44 |
| Avantor (AVTR) | United States | $7.841B | 11.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.099B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.850B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.116B | 36.46 |
| Bausch + Lomb (BLCO) | Canada | $5.819B | 38.21 |
| Sotera Health (SHC) | United States | $4.582B | 22.10 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.044B | 71.02 |
| Alignment Healthcare (ALHC) | United States | $3.298B | 0.00 |
| Concentras Parent (CON) | United States | $2.510B | 15.66 |
| Premier (PINC) | United States | $2.325B | 22.54 |
| Progyny (PGNY) | United States | $2.053B | 40.36 |
| Surgery Partners (SGRY) | United States | $2.036B | 26.24 |
| Ardent Health (ARDT) | United States | $2.011B | 7.76 |
| Establishment Labs Holdings (ESTA) | $1.989B | 0.00 | |
| Organon (OGN) | United States | $1.955B | 2.06 |
| Pediatrix Medical (MD) | United States | $1.942B | 11.60 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.342B | 0.00 |
| Omada Health (OMDA) | $1.205B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.053B | 16.83 |
| CareDx (CDNA) | United States | $0.863B | 14.10 |
| Embecta (EMBC) | United States | $0.832B | 4.87 |
| InnovAge Holding (INNV) | United States | $0.735B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.647B | 8.92 |
| Nutex Health (NUTX) | United States | $0.622B | 9.42 |
| Sonida Senior Living (SNDA) | United States | $0.600B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.547B | 0.00 |
| Pomdoctor - (POM) | China | $0.536B | 0.00 |
| Charming Medical (MCTA) | $0.497B | 0.00 | |
| CryoPort (CYRX) | United States | $0.443B | 0.00 |
| So-Young (SY) | China | $0.431B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 18.16 |
| Auna S.A (AUNA) | Luxembourg | $0.386B | 5.80 |
| SBC Medicals (SBC) | United States | $0.353B | 7.73 |
| Oncology Institute (TOI) | United States | $0.314B | 0.00 |
| KindlyMD (NAKA) | United States | $0.308B | 0.00 |
| Agilon Health (AGL) | United States | $0.257B | 0.00 |
| LifeMD (LFMD) | United States | $0.240B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.231B | 0.00 |
| Beauty Health (SKIN) | United States | $0.166B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.142B | 0.00 |
| DocGo (DCGO) | United States | $0.108B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.101B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.50 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |